Providing expansion capital to high growth life science companies
What we do
We invest in highly innovative, scalable life science companies that have recently reached, or are close to, the commercial stage, with strong long-term potential.
The combination of our long-term capital and sector expertise position us as an investor of choice for growth companies in the life science sector.
We are an engaged investor in, and a partner to life science companies at the leading edge of innovation.
We invest in companies harnessing the transformative power of biology and technology. In particular, we focus on investments in clinical diagnostics, industrial biotechnology, biologics supply chain, and healthcare IT.
We leverage our deep scientific knowledge, operational expertise and global network for the benefit of our portfolio companies.
We manage evergreen capital, which allows us to have a longer-term horizon and be a true partner dedicated to enabling our portfolio companies to fulfil their potential.
Growth Investments key figures
Follow-on investments executed during 2022
Number of Portfolio companies in 2022
Deployed during 2022
Our Growth Investments Portfolio
Meet our team